Bone Marrow Transplant Market, by Type (Autologous Transplant, Allogeneic Transplant, and Others), by Treatment Type (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative Disorders, Aplastic Anemia, Solid Tumors, Sickle cell Anemia, T

Bone Marrow Transplant Market, by Type (Autologous Transplant, Allogeneic Transplant, and Others), by Treatment Type (Leukemia, Lymphoma, Myeloma, Myelodysplastic Syndrome, Myeloproliferative Disorders, Aplastic Anemia, Solid Tumors, Sickle cell Anemia, Thalassemia, and Others), by End User (Hospitals, Multi-specialty Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030

A bone marrow transplant is a medical procedure that replaces the bone marrow with healthy cells. Replacement cells might come from either one’s own body or from a donor. A stem cell transplant, or more specifically, a hematopoietic stem cell transplant, is another name for a bone marrow transplant. Transplantation can be used to treat leukemia, myeloma, and lymphoma, as well as other blood and immune system illnesses that impact the bone marrow. Cancer and cancer treatment can damage the hematopoietic stem cells. Hematopoietic stem cells are blood-forming stem cells. Hematopoietic stem cells that are damaged may not develop into red blood cells, white blood cells, or platelets. These blood cells are vital, and each one serves a specific purpose. A bone marrow transplant can help the body regenerate the red blood cells, white blood cells, and platelets it requires.

Market Dynamics

Increasing efforts to set up centers for advanced research for bone marrow transplant (BMT) are expected to drive the market growth over the forecast period. For instance, on May 17, 2022, the Indian Council of Medical Research (ICMR) planned to set up centers for advanced research for bone marrow transplant (BMT) in government hospitals across India. The majority of bone marrow transplant centers are in the private sector, which limits access to treatment for the poor. Under this research model, ICMR will set up multiple centers that will work to provide affordable and safe bone marrow transplant procedures in all six regions of India, including north, south, east, west, north-east and central. The goal of this research model is to contribute towards development of bone marrow transplant, improve access to the established standard of care, and improve the outcome of bone marrow transplant.

Key features of the study:

• This report provides in-depth analysis of the global bone marrow transplant market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global bone marrow transplant market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Lonza, Merck KgaA, Sanofi, AllCells, STEMCELL Technologies Inc., Charles River Laboratories, Beike Biotechnology Co., Ltd., FUJIFILM Cellular Dynamics, Inc., CORESTEM, Inc., Gamida Cell, Lifeline Cell Technology, Mesoblast Ltd, and PromoCell GmbH
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global bone marrow transplant market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global bone marrow transplant market

Detailed Segmentation:

• Global Bone Marrow Transplant Market, By Type:
• Autologous Transplant
• Allogenic Transplant
• Others
• Global Bone Marrow Transplant Market, By Treatment Type:
• Leukemia
• Lymphoma
• Myeloma
• Myelodysplastic Syndrome
• Myeloproliferative Disorders
• Aplastic Anemia
• Solid Tumors
• Sickle cell Anemia
• Thalassemia
• Others
• Global Bone Marrow Transplant Market, By End User:
• Hospitals
• Multi-specialty Clinics
• Ambulatory Surgical Centers
• Global Bone Marrow Transplant Market, By Region:
• North America
• By Country
• U.S.
• Canada
• Latin America
• By Country
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• By Country
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• By Country
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of Asia Pacific
• Middle East
• By Country
• GCC
• Israel
• Rest of Middle East
• Africa
• By Region/Country
• South Africa
• Central Africa
• North Africa
• Company Profiles
• Lonza*
• Company Highlights
• Products Portfolio
• Key Highlights
• Financial Performance
• Strategies
• Merck KgaA
• Sanofi
• AllCells
• STEMCELL Technologies Inc.
• Charles River Laboratories
• Beike Biotechnology Co., Ltd.
• FUJIFILM Cellular Dynamics, Inc.
• CORESTEM, Inc.
• Gamida Cell
• Lifeline Cell Technology
• Mesoblast Ltd
• PromoCell GmbH

“*” marked represents similar segmentation in other categories in the respective section.